Here Are the Facts You Need to Understand WRB

By Blake Campbell • Friday, January 27 12:04 • Permanent Link

More and more people are talking about W.R. Berkley over the last few weeks. Is it worth buying the Property & Casualty Insurance stock at a price of $70.06? Only time will tell. The information below will give you a basic idea of what this investment may entail:

W.R. Berkley has moved 26.4% over the last year, and the S&P 500 logged a change of -8.4%
WRB has an average analyst rating of buy and is -14.75% away from its mean target price of $82.18 per share
Its trailing earnings per share (EPS) is $4.63
W.R. Berkley has a trailing 12 month Price to Earnings (P/E) ratio of 15.1 while the S&P 500 average is 15.97
Its forward earnings per share (EPS) is $5.59 and its forward P/E ratio is 12.5
The company has a Price to Book (P/B) ratio of 2.9 in contrast to the S&P 500's average ratio of 2.95
W.R. Berkley is part of the Financial Services sector, which has an average P/E ratio of 13.34 and an average P/B of 1.95
WRB has reported YOY quarterly earnings growth of -11.8% and gross profit margins of 0.4%
The company has a free cash flow of $2,182,024,960.00, which refers to the total sum of all its inflows and outflows of cash over the last quarter
W. R. Berkley Corporation, an insurance holding company, operates as a commercial lines writer in the United States and internationally. It operates in two segments, Insurance and Reinsurance & Monoline Excess.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.